Health Canada Medical Device Registration & MDEL Licensing
Navigate Canada's medical device regulatory pathway with confidence. From MDEL establishment licensing to Class II-IV device approval, MDSAP certification, and bilingual compliance — NexorTest is your trusted Canadian regulatory partner.
I-IV
MDSAP
Four Risk-Based Device Classes Under SOR/98-282
Health Canada classifies all medical devices into four risk categories. Your device class determines the registration pathway, documentation requirements, and review timeline.
Class I Devices
Lowest-risk devices including bandages, tongue depressors, and surgical instruments. No Medical Device Licence required — only an MDEL for the establishment importing, distributing, or manufacturing.
- 2-4 Weeks
- MDEL Only
- Low Risk
How is Class I registration different?
Class I devices require MDEL only, no device licence needed. Examples: bandages, tongue depressors, surgical instruments.
Class II Devices
Low-moderate risk devices such as contact lenses, pregnancy test kits, and ultrasound equipment. Requires both MDEL and Medical Device Licence via declaration review process.
- 3-6 Months
- MDEL + MDL
- MDSAP Required
What is needed for Class II devices?
Class III Devices
Moderate-high risk devices including orthopedic implants, glucose monitors, and hemodialysis systems. Requires pre-market review with clinical evidence by Health Canada’s Medical Devices Bureau.
- 6-12 Months
- Full Review
- Clinical Data
Is clinical data required for Class III?
Class III devices undergo pre-market review with clinical evidence. Examples: orthopedic implants, glucose monitors, hemodialysis.
Class IV Devices
Highest-risk devices including cardiac stents, pacemakers, heart valves, and IVDs for HIV/Hepatitis. Subject to full pre-market review with comprehensive clinical trial data assessment.
- 12-18 Months
- Full Assessment
- Clinical Trials
What does Class IV review involve?
Class IV devices require comprehensive pre-market review including clinical trial data. Examples: cardiac stents, pacemakers, heart valves.
Comprehensive Health Canada Registration Services
From initial classification through post-market surveillance, NexorTest manages every aspect of your Health Canada regulatory journey.
Health Canada Device Licensing (Class II-IV)
Complete Medical Device Licence (MDL) application preparation and submission for Class II, III, and IV devices. Includes declaration reviews, pre-market submissions, clinical evidence compilation, and MDALL database listing management.
MDEL Establishment Licensing
End-to-end Medical Device Establishment Licence application using Form FRM-0292. Covers importers, distributors, and manufacturers. Includes annual review management, activity updates, and compliance with the modernized MDEL framework (Nov 2025).
MDSAP Certification Support
Expert guidance through the Medical Device Single Audit Program (MDSAP) certification process. Mandatory since January 2019 for Class II-IV devices. Includes gap analysis, audit preparation, Auditing Organization coordination, and certificate maintenance.
Technical File & Dossier Preparation
Comprehensive technical documentation preparation including device description, risk analysis (ISO 14971), design verification and validation, biocompatibility data (ISO 10993), electrical safety (IEC 60601), and summary of safety and effectiveness.
ISO 13485 QMS Implementation
Full implementation of ISO 13485:2016 Quality Management System, the foundation standard required for MDSAP certification and Health Canada compliance. Gap analysis, documentation development, internal audit support, and certification body coordination.
Clinical Evidence & Evaluation Reports
Clinical evidence strategy and compilation for Class III and IV device submissions. Includes clinical evaluation reports, literature reviews, clinical investigation planning, and equivalence assessments to support safety and effectiveness claims.
IVD Registration Canada
Specialized In Vitro Diagnostic device registration covering IVD-specific risk classification (Class II through Class IV for HIV/Hepatitis), analytical and clinical performance evaluation, and Health Canada device licence applications for all IVD categories.
SaMD Regulatory Pathway Canada
Acquisition of import licenses for foreign manufacturers and manufacturing licenses for Indian producers. Includes authorized agent appointment, factory inspection preparation, and license maintenance with 5-year retention fees.
Post-Market Surveillance & Vanessa's Law Compliance
Comprehensive post-market surveillance under Vanessa's Law. Includes Mandatory Problem Reporting (MDPR), Type I/II recall management, 72-hour foreign risk notification, mandatory hospital incident reporting, and annual MDEL review compliance.
Canada's Trusted Health Canada Specialist
We combine deep Canadian regulatory expertise with global experience to deliver faster, more predictable Health Canada approvals.
Canada & Global Dual Expertise
Deep knowledge of Health Canada regulatory frameworks AND international regulatory systems. Our team understands the nuances of SOR/98-282, MDEL requirements, and how they interact with global submissions.
Design + Testing + Certification Under One Roof
Integrated services covering regulatory design review, safety and performance testing at our accredited labs, and complete regulatory certification — eliminating multi-vendor complexity and accelerating time to market.
MDSAP Specialists
Expert guidance through MDSAP certification — the gateway to 5 markets (Canada, US, Brazil, Japan, Australia). We help manufacturers achieve and maintain MDSAP compliance efficiently, reducing audit burden across multiple jurisdictions.
Multi-Region Expertise
Register in 40+ countries from a single partner. Simultaneous registrations across Health Canada, US FDA, EU MDR/CE, Saudi SFDA, CDSCO India, and TGA Australia — one integrated program for global market access.
Transparent Pricing & Fixed-Fee Packages
No hidden costs or hourly billing surprises. Our fixed-fee packages cover the complete scope from regulatory strategy through MDALL listing, with clear milestones and deliverables at every stage.
Six Steps to Your Health Canada Licence
A proven, structured approach that minimizes screening rejections and accelerates your path to the Canadian medical device market.
Device Classification & Regulatory Strategy
We determine your device’s risk classification (Class I, II, III, or IV) under SOR/98-282 and develop a tailored regulatory strategy including applicable standards, testing requirements, MDSAP readiness, and the optimal submission pathway.
MDSAP Certification & ISO 13485 QMS
We guide you through MDSAP certification via a recognized Auditing Organization, demonstrating ISO 13485:2016 compliance. This mandatory step for Class II-IV devices opens the gateway to five international markets simultaneously.
Technical Documentation & Bilingual Labeling
Our team prepares complete technical documentation including device description, risk analysis (ISO 14971), performance data, clinical evidence, and bilingual (English and French) labeling per Health Canada requirements.
MDEL & Device Licence Application
We submit the MDEL application (Form FRM-0292) for establishment licensing and the Medical Device Licence application for Class II-IV devices through the Drug and Health Products Portal (DHPP) with all supporting documentation and fees.
Health Canada Review & Query Resolution
We manage the entire review cycle, respond to screening and review queries promptly, provide supplementary information, and coordinate with Health Canada’s Medical Devices Bureau reviewers to resolve any deficiencies.
MDALL Listing & Post-Market Compliance
Upon approval, your device is listed in the MDALL database. We set up post-market surveillance under Vanessa’s Law, mandatory problem reporting (MDPR), recall management, and annual MDEL review compliance systems.
Health Canada Registration Across All Device Sectors
NexorTest supports medical device manufacturers across every therapeutic area and technology vertical entering the Canadian market.
- 🏥 Cardiovascular Devices
- 🦴 Orthopaedic Implants
- 🔬 In Vitro Diagnostics (IVD)
- 💻 Software as Medical Device (SaMD)
- 🧬 Dental Devices
- 👁 Ophthalmic Devices
- 🩺 Patient Monitoring Systems
- 💉 Drug Delivery Devices
- 🧠 Neurological Devices
- ❤ Wound Care Products
- 🏋 Rehabilitation Equipment
- 💡 AI/ML-Based Medical Devices
- 🩸 Blood Bank Equipment
- 📊 Imaging & Radiology Devices
- 🧪 Laboratory Instruments
- 🛡 Sterilization Equipment
Health Canada Registration FAQ
Expert answers to the most common questions about medical device registration with Health Canada.
What is Health Canada medical device registration?
Health Canada medical device registration is the mandatory regulatory process governed by the Medical Devices Bureau (MDB) under the Therapeutic Products Directorate (TPD) and Health Products and Food Branch (HPFB). Under the Food and Drugs Act and Medical Devices Regulations SOR/98-282 (last amended 2026-01-01), all medical devices manufactured in or imported into Canada must comply with Health Canada requirements. The process involves obtaining a Medical Device Establishment Licence (MDEL) for all importers, distributors, and manufacturers, and a Medical Device Licence (MDL) for Class II, III, and IV devices. Approved devices are listed in the MDALL database at health-products.canada.ca/mdall-limh/. Submissions are managed through the Drug and Health Products Portal (DHPP) at dhpp.hpfb-dgpsa.ca.
What are the Health Canada device classification classes?
Health Canada classifies medical devices into four risk-based classes under SOR/98-282. Class I represents low-risk devices such as bandages, tongue depressors, and surgical instruments — these require only an MDEL, no device licence. Class II covers low-moderate risk devices like contact lenses, pregnancy test kits, and ultrasound equipment — requiring MDEL plus MDL via declaration review (3-6 months). Class III includes moderate-high risk devices such as orthopedic implants, glucose monitors, and hemodialysis systems — requiring pre-market review (6-12 months). Class IV encompasses the highest-risk devices including cardiac stents, pacemakers, heart valves, and IVDs for HIV/Hepatitis — requiring full pre-market review with clinical trial data (12-18 months).
What is MDEL and who needs one?
A Medical Device Establishment Licence (MDEL) is required for ALL entities that import, distribute, or manufacture medical devices in Canada. This includes Canadian manufacturers, foreign manufacturers selling into Canada, importers, and distributors. The MDEL application is submitted using Form FRM-0292 to Health Canada’s Medical Devices Bureau. The annual fee is $5,426 (2025). The MDEL must be reviewed annually and updated whenever there are changes to the establishment’s activities, address, or device listings. Even Class I devices, which do not require a Medical Device Licence (MDL), still require the establishment to hold a valid MDEL. The modernized MDEL framework published in the Canada Gazette (Nov 2025) introduces enhanced requirements for establishment licensing.
Is MDSAP mandatory for Canada?
Yes, the Medical Device Single Audit Program (MDSAP) has been mandatory for Canada since January 1, 2019, replacing the former Canadian Medical Devices Conformity Assessment System (CMDCAS). All manufacturers of Class II, III, and IV medical devices sold in Canada must hold a valid MDSAP certificate. MDSAP audits are conducted by recognized Auditing Organizations and cover QMS requirements of five participating regulatory authorities: Canada (Health Canada), United States (FDA), Brazil (ANVISA), Japan (MHLW/PMDA), and Australia (TGA). The MDSAP certificate serves as evidence of ISO 13485:2016 compliance for Health Canada device licence applications.
What documents are required for Class III/IV device licensing?
Health Canada Class III/IV device licence applications require: device description and intended use, MDSAP certificate demonstrating ISO 13485:2016 compliance, risk analysis report (ISO 14971), design verification and validation evidence, biocompatibility test reports (ISO 10993), electrical safety reports (IEC 60601 if applicable), software documentation per IEC 62304 (for software-containing devices), clinical evidence including clinical investigation data or literature reviews, sterility validation (if applicable), bilingual labeling in English and French, Unique Device Identification (UDI) information, and a summary of safety and effectiveness. Class IV devices additionally require comprehensive clinical trial data and may qualify for priority review pathways.
How long does Health Canada device registration take?
Health Canada device registration timelines vary by class. Class I devices require only an MDEL, typically processed within 2-4 weeks. Class II devices undergo declaration review, taking approximately 3-6 months (fee: ~$5,426 MDEL + device licence fees). Class III devices require pre-market review and generally take 6-12 months. Class IV devices undergo full pre-market review with clinical data, typically requiring 12-18 months. Timelines depend on documentation completeness, device complexity, clinical evidence requirements, and Health Canada query response cycles. NexorTest’s experts help streamline the process with complete submissions that minimize screening rejections and review queries.
Does Canada require bilingual labeling?
BIS (Bureau of Indian Standards) certification is mandatory for specific categories of medical devices notified by the Indian government under compulsory registration orders. Currently, devices such as cardiac stents, condoms, surgical gloves, and certain electronic medical equipment require BIS certification in addition to CDSCO registration. BIS certification involves product testing at BIS-recognized labs, factory inspection, and grant of ISI mark license. NexorTest assists manufacturers with both CDSCO registration and BIS certification to ensure complete regulatory compliance in India.
Can NexorTest help with IVD and SaMD registration in Canada?
Yes, NexorTest provides specialized Health Canada registration services for In Vitro Diagnostic (IVD) devices and Software as a Medical Device (SaMD). For IVDs, we handle classification under the appropriate risk class (Class II for low-risk IVDs up to Class IV for HIV/Hepatitis diagnostics), analytical and clinical performance evaluation, and device licence applications. For SaMD, we manage software lifecycle documentation per IEC 62304, cybersecurity risk assessments, clinical evidence for AI/ML-based devices, and regulatory strategy aligned with Health Canada’s evolving digital health framework. Our team has extensive experience navigating Health Canada’s review processes for both IVD and SaMD categories, including pre-submission meetings and priority review pathways.
Ready to Enter the Canadian Medical Device Market?
Get a free Health Canada regulatory assessment from Canada’s leading medical device registration consultants. Our experts will map your fastest path to market.
Accreditations & Certifications
Accredited Labs
QMS Certified
National Accreditation
Bureau of Indian Standards
Recognised Consultant
Expand Beyond Canada with Multi-Market Access
Leverage NexorTest's global regulatory network to register your medical device in 40+ markets from a single integrated program.
US FDA 510(k)
EU MDR CE Marking
EU IVDR
UK UKCA / MHRA
Saudi SFDA
UAE MoHAP
TGA Australia